Patents by Inventor Michael J. DiPrima

Michael J. DiPrima has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RECEPTOR TYROSINE KINASE INHIBITORS FOR TREATMENT OF PROTEIN KINASE MODULATION-RESPONSIVE DISEASE OR DISORDER
    Publication number: 20220194943
    Abstract: Ephrin type receptor tyrosine kinase inhibitors, also known as Eph tyrosine kinase receptor inhibitors, for treating cancer, an inflammatory disease, an autoimmune disease, or a degenerative disease characterized at least in part by the abnormal activity or expression of the Eph receptor tyrosine kinase. The inhibitors are particularly useful for treating certain cancers.
    Type: Application
    Filed: March 11, 2022
    Publication date: June 23, 2022
    Applicants: THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Servic, Johann Wolfgang Goethe-Universität, Deutsches Krebsforschungszentrum
    Inventors: Giovanna Tosato, Michael J. DiPrima, Harald Schwalbe, Alix Tröster, Denis Kudlinzki, Nathalie Jores